We will extend the MARK4 intervention time or reduce the blood glucose level of DCM mice in subsequent studies to observe the effects of MARK4 on myocardial lipid oxidation metabolism under conditions of high and normal blood glucose levels. Here, MARK4 is linked to familial dilated cardiomyopathy.